Cargando…

Association Between Claims‐Defined Frailty and Outcomes Following 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND‐DAPT Study

BACKGROUND: Frailty is rarely assessed in clinical trials of patients who receive dual antiplatelet therapy (DAPT) after percutaneous coronary intervention. This study investigated whether frailty defined using claims data is associated with outcomes following percutaneous coronary intervention, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Faridi, Kamil F., Strom, Jordan B., Kundi, Harun, Butala, Neel M., Curtis, Jeptha P., Gao, Qi, Song, Yang, Zheng, Luke, Tamez, Hector, Shen, Changyu, Secemsky, Eric A., Yeh, Robert W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382113/ https://www.ncbi.nlm.nih.gov/pubmed/37449567 http://dx.doi.org/10.1161/JAHA.123.029588

Ejemplares similares

Prognosis of Claims‐ Versus Trial‐Based Ischemic and Bleeding Events Beyond 1 Year After Coronary Stenting
por: Butala, Neel M., et al.
Publicado: (2021)

Association of Frailty With Treatment Selection and Long‐Term Outcomes Among Patients With Chronic Limb‐Threatening Ischemia
por: Butala, Neel M., et al.
Publicado: (2021)

The effects of dual antiplatelet therapy (DAPT) adherence on survival in patients undergoing revascularization and the determinants of DAPT adherence
por: Zhang, Shuqi, et al.
Publicado: (2022)

Short versus prolonged dual antiplatelet therapy (DAPT) duration after coronary stent implantation: A comparison between the DAPT study and 9 other trials evaluating DAPT duration
por: Toyota, Toshiaki, et al.
Publicado: (2017)

Dual Antiplatelet Therapy (DAPT) versus No Antiplatelet Therapy and Incidence of Major Bleeding in Patients on Venoarterial Extracorporeal Membrane Oxygenation
por: Staudacher, Dawid L., et al.
Publicado: (2016)

Formal comment to Toyota et al.: Short versus prolonged dual antiplatelet therapy (DAPT) duration after coronary stent implantation: A comparison between the DAPT study and 9 other trials evaluating DAPT duration
por: Elmariah, Sammy
Publicado: (2017)

Identification of Frailty Using a Claims‐Based Frailty Index in the CoreValve Studies: Findings from the EXTEND‐FRAILTY Study
por: Strom, Jordan B., et al.
Publicado: (2021)

Association of entirely claims-based frailty indices with long-term outcomes in patients with acute myocardial infarction, heart failure, or pneumonia: a nationwide cohort study in Turkey
por: Kundi, Harun, et al.
Publicado: (2021)

Implementing a pharmacogenetic-driven algorithm to guide dual antiplatelet therapy (DAPT) in Caribbean Hispanics: protocol for a non-randomised clinical trial
por: Hernandez-Suarez, Dagmar F, et al.
Publicado: (2020)

The Cornelian dilemma(†) of quitting DAPT
por: Motovska, Zuzana, et al.
Publicado: (2021)

Correlations of DAPT score and PRECISE-DAPT score with the extent of coronary stenosis in acute coronary syndrome
por: Long, Tianyi, et al.
Publicado: (2018)

Contradictions between DAPT and PRECISE-DAPT scores with the severity of coronary lesion in acute coronary syndrome
por: Bi, Sisi, et al.
Publicado: (2020)

The Role of Dual Antiplatelet Therapy (DAPT) vs Surgery in a Case of Moyamoya Disease: A Case Report and Review of the Literature
por: Yadav, Ruchi, et al.
Publicado: (2023)

Dissemination of 2014 dual antiplatelet therapy (DAPT) trial results: a systematic review of scholarly and media attention over 7 months
por: Sharp, Melissa K, et al.
Publicado: (2017)

Performance of PRECISE-DAPT and Age–Bleeding–Organ Dysfunction Score for Predicting Bleeding Complication During Dual Antiplatelet Therapy in Chinese Elderly Patients
por: Dong, Liang, et al.
Publicado: (2022)

Is the duration of dual antiplatelet therapy (DAPT) excessive in post-angioplasty in chronic coronary syndrome? Data from the France-PCI registry (2014–2019)
por: Mezier, A., et al.
Publicado: (2023)

Predicting Residual Angina After Chronic Total Occlusion Percutaneous Coronary Intervention: Insights from the OPEN‐CTO Registry
por: Butala, Neel M., et al.
Publicado: (2022)

A comparison of safety and efficacy between long-term DAPT and intensive statins combined with short-term DAPT for acute ischemic stroke
por: Deng, Ting, et al.
Publicado: (2023)

Use of Chronic Oral Anticoagulation and Associated Outcomes Among Patients Undergoing Percutaneous Coronary Intervention
por: Secemsky, Eric A., et al.
Publicado: (2016)

Causes and predictors of early readmission after percutaneous coronary intervention among patients discharged on oral anticoagulant therapy
por: Vidula, Mahesh K., et al.
Publicado: (2018)

DAPT Enhances the Apoptosis of Human Tongue Carcinoma Cells
por: Grottkau, Brian E, et al.
Publicado: (2009)

Should the findings of the DAPT trial change my practice?
Publicado: (2016)

Long‐Term Outcomes and Duration of Dual Antiplatelet Therapy After Coronary Intervention With Second‐Generation Drug‐Eluting Stents: The Veterans Affairs Extended DAPT Study
por: Kinlay, Scott, et al.
Publicado: (2023)

Trends in Spending and Claims for P2Y12 Inhibitors by Medicare and Medicaid From 2015 to 2020
por: Essa, Mohammed, et al.
Publicado: (2023)

Contextualizing the BEST-CLI Trial Results in Clinical Practice
por: Butala, Neel M., et al.
Publicado: (2023)

Applicability of the PRECISE-DAPT score in elderly patients with myocardial infarction
por: Guerrero, Carme, et al.
Publicado: (2018)

DAPT: A package enabling distributed automated parameter testing
por: Duggan, Ben, et al.
Publicado: (2021)

Frailty and mortality associations in patients with COVID‐19: a systematic review and meta‐analysis
por: Subramaniam, Ashwin, et al.
Publicado: (2022)

Provision of a DAPT Score to Cardiologists and Extension of Dual Antiplatelet Therapy Beyond 1 Year After ACS: Randomized Substudy of the Prospective Canadian ACS Reflective II Study
por: Arbel, Yaron, et al.
Publicado: (2021)

Improvements in Coronary Stent Design Translate to Better Real-World Outcomes
por: Butala, Neel M., et al.
Publicado: (2021)

Short-term DAPT after coronary stenting has similar ischemic and bleeding outcomes as long-term DAPT: a 5-year population-based cohort study
por: Balaji Srinivasan, Sriraag, et al.
Publicado: (2022)

DAPT in the control of human hair follicle stem cell proliferation and differentiation
por: Jiang, Jindou, et al.
Publicado: (2014)

Risk prediction of bleeding and MACCE by PRECISE-DAPT score post-PCI
por: Dannenberg, Lisa, et al.
Publicado: (2021)

Validation of the 4‐Item PRECISE‐DAPT Score: A SWEDEHEART Study
por: Wester, Axel, et al.
Publicado: (2021)

VEGF combined with DAPT promotes tissue regeneration and remodeling in vascular grafts
por: Yang, Tao, et al.
Publicado: (2023)

Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trial
por: Kedhi, Elvin, et al.
Publicado: (2018)

Comparative Assessment of Predictive Performance of PRECISE-DAPT, CRUSADE, and ACUITY Scores in Risk Stratifying 30-Day Bleeding Events
por: Kawashima, Hideyuki, et al.
Publicado: (2020)

Effect of DAPT, a gamma secretase inhibitor, on tumor angiogenesis in control mice
por: Kalantari, Elmira, et al.
Publicado: (2013)

Notch signaling inhibitor DAPT provides protection against acute craniocerebral injury
por: Zhang, Hong-Mei, et al.
Publicado: (2018)

Perspectives on Efficiency and Quality in an Ever Changing System: Healthcare 2010
por: Butala, Neel
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_viaqc80mf9ohi1o6g99o6bbiir